Résumé
La chimiothérapie néoadjuvante (CNA) constitue maintenant une des méthodes standards pour traiter les cancers du sein dans le but de permettre, dans certaines conditions, un traitement conservateur pour des tumeurs initialement avancées [1], [2]. Il est nécessaire d’optimiser l’approche chirurgicale tant pour le traitement de la tumeur mammaire que pour le geste axillaire.
This is a preview of subscription content, log in via an institution to check access.
Preview
Unable to display preview. Download preview PDF.
Références
Bear HD. (2010) Neoadjuvant chemotherapy for operable breast cancer: individualizing locoregional and systemic therapy. Surg Oncol Clin N Am 19: 607–626
Kaufmann M, von Minckwitz G, Mamounas EP et al. (2012) Recommendations from an international consensus conference on the current status and future of neoadjuvant systemic therapy in primary breast cancer. Ann Surg Oncol 19: 1508–1516
L’IRM mammaire dans le bilan d’extension locorégionale préthérapeutique du cancer du sein. (2010) http://www.has-sante.fr/portail/upload/docs/application/pdf/2012-01/synthese_irm_mammaire.pdf
Zhang L, Liu C, Wang W et al. (2012) Is optimal timing of sentinel lymph node biopsy before neoadjuvant chemotherapy in patients with breast cancer? A literature review. Surg Oncol [Epub ahead of print]
Kaufmann M, vonMinckwitz G, Bear HD et al. (2007) Recommendations from an international expert panel on the use of neoadjuvant (primary) systemic treatment of operable breast cancer: new perspectives 2006. Ann Oncol 18: 1927–1934
Kaufmann M, Morrow M, von Minckwitz G, et al. (2010) Locoregional treatment of primary breast cancer: consensus recommendations from an International Expert Panel. Cancer 116: 1184–1191
Rouzier R, Pusztai L, Garbay JR et al. (2006) Development and validation of nomograms for predicting residual tumor size and the probability of successful conservative surgery with neoadjuvant chemotherapy for breast cancer. Cancer 107: 1459–1466
Wolmark N, Wang J, Mamounas E et al. (2001) Preoperative chemotherapy in patients with operable breast cancer: nine-year results from National Surgical Adjuvant Breast and Bowel Project B-18. J Natl Cancer Inst Monogr 30: 96–102
Rouzier R, Mathieu MC, Sideris L et al. (2004) Breast-conserving surgery after neoadjuvant anthracycline-based chemotherapy for large breast tumors. Cancer 101: 918–925
Rouzier R, Extra JM, Carton M et al. (2001) Primary chemotherapy for operable breast cancer: incidence and prognostic significance of ipsilateral breast tumor recurrence after breast-conserving surgery. J Clin Oncol 19: 3828–3835
Chen AM, Meric-Bernstam F, Hunt KK et al. (2005) Breast conservation after neoadjuvant chemotherapy: A prognostic index for clinical decision-making. Cancer 103: 689–695
Akay CL, Meric-Bernstam F, Hunt KK et al. (2012) Evaluation of the MD Anderson Prognostic Index for local-regional recurrence after breast conserving therapy in patients receiving neoadjuvant chemotherapy. Ann Surg Oncol 19: 901–907
Huang EH, Strom EA, Perkins GH et al. (2006) Comparison of risk of local-regional recurrence after mastectomy or breast conservation therapy for patients treated with neoadjuvant chemotherapy and radiation stratified according to a prognostic index score. Int J Radiat Oncol Biol Phys 66: 352–357
Caudle AS, Yu TK, Tucker SL et al. (2012) Local-regional control according to surrogate markers of breast cancer subtypes and response to neoadjuvant chemotherapy in breast cancer patients undergoing breast conserving therapy. Breast Cancer Res 14: R83
Gouy S, Rouzier R, Missana MC et al. (2005) Immediate reconstruction after neoadjuvant chemotherapy: effect on adjuvant treatment starting and survival. Ann Surg Oncol 12: 161–166
Decker MR, Greenblatt DY, Havlena J et al. (2012) Impact of neoadjuvant chemotherapy on wound complications after breast surgery. Surgery (in press)
Kronowitz SJ, Robb GL (2009) Radiation Therapy and Breast Reconstruction: A Critical Review of the Literature. Plast Reconstr Surg 124: 395–408
1van Deurzen CH, Vriens BE, Tjan-Heijnen VC et al. (2009) Accuracy of sentinel node biopsyafter neoadjuvant chemotherapy in breast cancer patients: a systematic review. Eur J Cancer 45: 3124–3130
GANEA 2: Essai évaluant l’efficacité de la technique du ganglion axillaire sentinelle après chimiothérapie néoadjuvante, chez des patientes ayant un cancer du sein. http://www.e-cancer. fr/recherche/recherche-clinique/registre-des-essais-cliniques/registre-des-essais-cliniques/detailsetude? idFiche=1543
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer-Verlag France, Paris
About this paper
Cite this paper
Rouzier, R., Bezu, C., Reyal, F., Coutant, C., Atallah, D., Chereau, E. (2013). Quelle chirurgie après chimiothérapie néoadjuvante ?. In: Acquis et limites en sénologie / Assets and limits in breast diseases. Springer, Paris. https://doi.org/10.1007/978-2-8178-0396-8_16
Download citation
DOI: https://doi.org/10.1007/978-2-8178-0396-8_16
Publisher Name: Springer, Paris
Print ISBN: 978-2-8178-0395-1
Online ISBN: 978-2-8178-0396-8